BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 36831559)

  • 1. Clinical Scores, Biomarkers and IT Tools in Lung Cancer Screening-Can an Integrated Approach Overcome Current Challenges?
    Voigt W; Prosch H; Silva M
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-off low-dose CT screening of positive nodules in lung cancer: A prospective community-based cohort study.
    Xiao H; Shi Z; Zou Y; Xu K; Yu X; Wen L; Liu Y; Chen H; Long H; Chen J; Liu Y; Cao S; Li C; Hu Y; Liao X; Yan S
    Lung Cancer; 2023 Mar; 177():1-10. PubMed ID: 36657367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of a deep learning-based lung nodule detection system as an alternative reader in a Chinese lung cancer screening program.
    Cui X; Zheng S; Heuvelmans MA; Du Y; Sidorenkov G; Fan S; Li Y; Xie Y; Zhu Z; Dorrius MD; Zhao Y; Veldhuis RNJ; de Bock GH; Oudkerk M; van Ooijen PMA; Vliegenthart R; Ye Z
    Eur J Radiol; 2022 Jan; 146():110068. PubMed ID: 34871936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probability of cancer in pulmonary nodules detected on first screening CT.
    McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
    N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between lung cancer probability and number of pulmonary nodules in baseline computed tomography lung cancer screening: A retrospective study based on the Chinese population.
    Wu Q; Zhao S; Huang Y; Wang J; Tang W; Zhou L; Qi L; Zhang Z; Xie Y; Zhang J; Li H; Wu N
    Front Oncol; 2022; 12():1061242. PubMed ID: 36686791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening.
    Hadique S; Jain P; Hadi Y; Baig A; Parker JE
    BMC Med Imaging; 2020 Jun; 20(1):69. PubMed ID: 32571221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and size measurements of pulmonary nodules in ultra-low-dose CT with iterative reconstruction compared to low dose CT.
    Sui X; Meinel FG; Song W; Xu X; Wang Z; Wang Y; Jin Z; Chen J; Vliegenthart R; Schoepf UJ
    Eur J Radiol; 2016 Mar; 85(3):564-70. PubMed ID: 26860668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Quantitative Imaging Biomarker Alliance in optimizing CT for the evaluation of lung cancer screen-detected nodules.
    Mulshine JL; Gierada DS; Armato SG; Avila RS; Yankelevitz DF; Kazerooni EA; McNitt-Gray MF; Buckler AJ; Sullivan DC
    J Am Coll Radiol; 2015 Apr; 12(4):390-5. PubMed ID: 25842017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol and Rationale for the International Lung Screening Trial.
    Lim KP; Marshall H; Tammemägi M; Brims F; McWilliams A; Stone E; Manser R; Canfell K; Weber M; Connelly L; Bowman RV; Yang IA; Fogarty P; Mayo J; Yee J; Myers R; Atkar-Khattra S; Lam DCL; Rosell A; Berg CD; Fong KM; Lam S;
    Ann Am Thorac Soc; 2020 Apr; 17(4):503-512. PubMed ID: 32011914
    [No Abstract]   [Full Text] [Related]  

  • 17. Screen-detected solid nodules: from detection of nodule to structured reporting.
    Silva M; Milanese G; Ledda RE; Pastorino U; Sverzellati N
    Transl Lung Cancer Res; 2021 May; 10(5):2335-2346. PubMed ID: 34164281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
    Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
    Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
    Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
    J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.